¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
¸ðüžÆÀÇÇР  /    »ý½Ä³»ºÐºñÇР  /    ºÎÀÎÁ¾¾çÇР  /    ÀϹݺÎÀΰúÇÐ
Æ÷½ºÅÍ : ºÎÀÎÁ¾¾çÇÐ - ÀϽà : 2015³â 9¿ù 18ÀÏ(±Ý) ~ 2015³â 9¿ù 19ÀÏ(Åä)
- Àå¼Ò : EXHIBITION HALL B[1F]
(07:00~07:00)
89-GO107:00~07:00 °­ÁöÀº
¿¬¼¼´ëÇб³ ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø »êºÎÀΰú
Basaloid Squamous Cell Carcinoma of the Uterine Cervix: A Case Report
90-GO207:00~07:00 °íÁ¤È­
°­¿ø´ëÇб³º´¿ø »êºÎÀΰú
5¼¼ ¿©¾Æ¿¡¼­ ¹ß»ýÇÑ °ñ¹Ý³» Á¾±«¿¡ ´ëÇÑ º¹°­°æÀû ¼ö¼ú ¼º°ø 1¿¹
91-GO307:00~07:00 °øÁø°æ
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Primary ovarian mucinous carcinoid with metastatic adenocarcinoma in the contralateral ovary
92-GO407:00~07:00 °øÅ¿í
¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú
Pure large neuroendocrine carcinoma of the endometrium: A case report
93-GO507:00~07:00 °øÅ¿í
¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú
A predictive model for parametrial invasion in patients with FIGO stage IB cervical cancer: individualized approach for primary treatment
94-GO607:00~07:00 °øÅ¿í
¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú
Ultrasound-guided intranodal lymphangiography with glue embolization: A novel technique to treat chylous or lymphatic ascites after retroperitoneal lymphadenectomy in gynecologic cancer
95-GO707:00~07:00 È«ÁøÈ­
°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú
CXCL11 mediates Twist-induced angiogenesis in epithelial ovarian cancer cell line
96-GO807:00~07:00 ±Çº´¼ö
¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú
Clinical determination of the appropriate time of removal of surgical drain in patients undergoing lymphadenectomy for the treatment of gynecologic cancer
97-GO907:00~07:00 ±Çº¸¶÷
Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú
Choriocarcinoma Presenting Isolated Adrenal Metastasis: A case report
98-GO1007:00~07:00 ±âÀº¿µ
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
Incidence and risk factors of lower extremity lymphedema after gynecologic surgery in ovarian cancer
99-GO1107:00~07:00 ±èµ¿¿í
ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø »êºÎÀΰú
The characteristics of Type II endometrial cancer.
100-GO1207:00~07:00 ±è¹Î°æ
À»ÁöÀÇ´ë À»Áöº´¿ø »êºÎÀΰú
Krukenberg tumor in pregnancy mimicking preeclampsia.
101-GO1307:00~07:00 ±è¼±¾Æ
The impact of 10 most common HPV genotypes on the progression of cervical cytology in women with ASCUS or LSIL: The Korean HPV cohort study
102-GO1407:00~07:00 ±è¼ÒÀ±
Incidental Serous Tubal Intraepithelial Carcinoma and Invasive Serous Carcinoma related with BRCA mutation
103-GO1507:00~07:00 ±èÀ±È­
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Subserosal leiomyosarcoma of the uterus mimicking ovarian carcinoma in a postmenopausal woman : a case report
104-GO1607:00~07:00 ±èÁöÇý
Ä¥°î°æºÏ´ëÇб³º´¿ø »êºÎÀΰú
Solitary retroperitoneal pelvic metastasis mimicking ovarian fibroma from hepatocellular carcinoma: a case report
105-GO1707:00~07:00 ±èÅÂÇö
°Ç¾ç´ëÇб³º´¿ø »êºÎÀΰú
HPV TYPE ATTRIBUTION AT DIFFERENT STAGES OF CERVICAL LESIONS PROVEN BY CONIZATION BIOPSY : A SINGLE CENTER
106-GO1807:00~07:00 ±èÅÂÈÆ
¿øÀÚ·ÂÀÇÇпø »êºÎÀΰú
Pelvic Reirradiation as an effective alternative to pelvic exenteration in recurrent cervical cancer
107-GO1907:00~07:00 ±èÅÂÈñ
¼øõÇâÀÇ´ë ºÎõº´¿ø »êºÎÀΰú
Vagina Leiomyosarcoma : a Case Peport
108-GO2007:00~07:00 ±èÈ¿Áø
ÀüÁÖ¿¹¼öº´¿ø »êºÎÀΰú
Vaginal melanoma with uterine prolapse
109-GO2107:00~07:00 ±èÈñ½Â
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Laparoscopic or Robot-assisted Radical Trachelectomy with Type C1 Parametrectomy and Preservation of the Uterine Artery for Women With Early-stage Cervical Cancer: A Prospective Pilot Study
110-GO2207:00~07:00 ±èÈñÁ¤
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Obesity is associated with higher long non-coding RNA SRA expression in endometrial cancer
111-GO2307:00~07:00 ±èÈñÁ¤
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Upregulation of long non-coding RNA HOXA11 antisense promotes tumor metastasis via the Notch signaling pathway in cervical cancer
112-GO2407:00~07:00 ¹Ú½½±â
ÀüÁÖ¿¹¼öº´¿ø »êºÎÀΰú
°ñ¹Ý°­°ú º¹°­ ³»·Î ÀüÆĵÇÁö ¾Ê°í Èĺ¹¸·ÀÓÆÄÀý¿¡ ÀüÀÌµÈ ³­¼Ò¾Ï 1¿¹
113-GO2507:00~07:00 º¯Á¤¹Ì
ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú
Efficacy of Human Papillomavirus Vaccines to Prevent the Recurrence of Cervical Intraepithelial Neoplasia
114-GO2607:00~07:00 ¼ºÁß¿±
ÇѸ²ÀÇ´ë ¼º½Éº´¿ø »êºÎÀΰú
Concurrent chemoradiation is better than systemic chemotherapy as a postoperative adjuvant therapy in advanced cervical cancer
115-GO2707:00~07:00 ¼ºÇýÀ±
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¿©¼º¾ÏÁ¤º¹ Ư¼ºÈ­ ¿¬±¸¼¾ÅÍ
Aberrant epigenetic regulation of gamma-aminobutyrate type A receptor pi subunit (GABRP) associated with aggressive phenotype of ovarian cancer.
116-GO2807:00~07:00 ¼Û¹ÎÁ¾
°¡Å縯ÀÇ´ë ´ëÀü¼º¸ðº´¿ø »êºÎÀΰú
Inhibitory effect of snake venom toxin on NF-¥êB activity prevents human cervical cancer cell growth via increase of death receptor 3 and 5 expression.
117-GO2907:00~07:00 ¼Û¹ÎÁ¾
°¡Å縯ÀÇ´ë ´ëÀü¼º¸ðº´¿ø »êºÎÀΰú
Single port laparoscopic posterior pelvic exenteration
118-GO3007:00~07:00 ¼ÛÀº¼·
ÀÎÇÏ´ëÇб³º´¿ø »êºÎÀΰú
The clinical data of the patients with endometrioid endometrial cancer at an institution in Korea
119-GO3107:00~07:00 ¼ÛÁö¿µ
°¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú
Primary small cell neuroendocrine carcinoma of the vagina – A Case Report
120-GO3207:00~07:00 ½ÅÁ¤±Ô
°æ»ó´ëÇб³º´¿ø »êºÎÀΰú
Transcriptional activation of E6/E7 oncogenes by O-GlcNAcylated HCF-1 in HPV16/18-infected cervical cancers
121-GO3307:00~07:00 À¯±ÔºÀ
´Ü±¹´ëÇб³º´¿ø »êºÎÀΰú
Primary Ovarian Leiomyoma With Typical Meigs' Syndrome
122-GO3407:00~07:00 À°Áø¼º
°­¼­¹ÌÁî¸Þµðº´¿ø »êºÎÀΰú
Comparison of survival outcomes in women with unsuspected uterine malignancy diagnosed after laparotomic versus laparoscopic myomectomy: A national, population-based study
123-GO3507:00~07:00 À±°¡¿µ
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Disseminated polypoid endometriosis of the ovary mimicking advanced ovarian cancer: a case report and literature review
124-GO3607:00~07:00 À±°¡¿µ
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Mixed endometrial stromal and smooth muscle tumor of the uterus in a postmenopausal woman: a case report
125-GO3707:00~07:00 À±Á¤¿ø
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
The therapeutic and prognostic significance of systematic lymphadenectomy in patients with advanced ovarian cancer at the time of interval debulking surgery after neoadjuvant chemotherapy
126-GO3807:00~07:00 ÀÌ°¡À»
ÀüºÏ´ëÇб³º´¿ø »êºÎÀΰú
Leiomyomatosis peritonealis disseminata: a case report
127-GO3907:00~07:00 ÀÌ°æ³ë
ÇѸ²ÀÇ´ë °­³²¼º½Éº´¿ø »êºÎÀΰú
Single-Lesion Measurement per Organ for Assessing Tumor Response in Advanced Ovarian Cancer
128-GO4007:00~07:00 ÀÌ´ë¿ì
°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø »êºÎÀΰú
SUPERIOR MESENTERIC ARTERY SYNDROME IN PATIENT WITH CERVICAL CANCER : A CASE REPORT
129-GO4107:00~07:00 À̸¶¸®¾Æ
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Postoperative radiotherapy versus chemoradiotherapy in stage III-IV endometrial cancer
130-GO4207:00~07:00 ÀÌ¿µÀç
¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú
Feasibility of uterine preservation in the management of early- stage uterine adenosarcomas: a single institute experience
131-GO4307:00~07:00 ÀÌÀ¯¿µ
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Dynamin inhibitors as a new anti-cancer agent in cervical carcinoma
132-GO4407:00~07:00 ÀÌÀ±°æ
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
Comparison of the HPV DNA chip test, the real time PCR HPV test and the Hybrid capture II test in Atypical Squamous Cells of Undetermined Significance population
133-GO4507:00~07:00 ÀÌÀ翬
¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø »êºÎÀΰú
Analysis of clinicopathologic factors for subsequent surgery after initial conization with positive resection margins
134-GO4607:00~07:00 ÀÌÁ¤¿ø
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
HER2 as a Novel Therapeutic Target for Cervical Cancer
135-GO4707:00~07:00 ÀÌÁÖÇÐ
°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú
Peritoneal leiomyosarcoma arising from disseminated peritoneal leiomyomatosis after hysterectomy
136-GO4807:00~07:00 ÀÌÅÂÀÓ
ÇѸ²ÀÇ´ë µ¿Åº¼º½Éº´¿ø »êºÎÀΰú
A malignant ovarian steroid cell tumor in a postmenopausal woman, managed with laparoscopic surgical staging: a case report
137-GO4907:00~07:00 ÀÌÇöÁÖ
¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú
Comparison of MRI and 18F-FDG PET/CT in the Preoperative Evaluation of Uterine Carcinosarcoma
138-GO5007:00~07:00 ÀåűÔ
°è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú
A retrospective comparison of Patient with locally advanced early stage cervical cancer(IB2~IIA) treated with concurrent chemoradiation versus radical hysterectomy with or without adjuvant therapy
139-GO5107:00~07:00 ÀüÁöÇö
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
Robot-assisted laparoscopic adenomyomectomy of adenomyotic nodule implanted on uterine endometrium manifesting as endometrial cancer
140-GO5207:00~07:00 Á¤µµ¿µ
¾È¾ç»ùº´¿ø
The easy tying technique during single port laparoscopic surgery
141-GO5307:00~07:00 Á¤¼öÈ£
¼øõÇâÀÇ´ë ºÎõº´¿ø »êºÎÀΰú
ÀӽŠÁß ¹ß°ßÇÑ Àڱ󻸷±âÁúÀ°Á¾ 1¿¹
142-GO5407:00~07:00 Á¤¾ð¼®
ÇѸ²ÀÇ´ë ÇÑ°­¼º½Éº´¿ø »êºÎÀΰú
Technical and anatomical description of surgical boundary for systemic laparoscopic para-aortic lymphadenectomy up to the left renal vein level for women with gynecologic cancers
143-GO5507:00~07:00 Á¤À¯¿¬
°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø »êºÎÀΰú
Effective therapeutic strategy for massive retroperitoneal hematoma after conization: arterial embolization and pig-tail catheter insertion
144-GO5607:00~07:00 Á¶µ¿ÈÞ
ÀüºÏ´ëÇб³º´¿ø »êºÎÀΰú
³­¼Ò¾Ï ¼¼Æ÷ÁÖ¿¡¼­ AveULTRAÀÇ Ç×¾Ï È¿´É ¿¬±¸
145-GO5707:00~07:00 Á¶Çö¿õ
°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú
Correlation between the serum CA-125 levels and imaging findings after surgery in patients with epithelial ovarian cancer
146-GO5807:00~07:00 Á¶Çý¿¬
ÇѸ²ÀÇ´ë µ¿Åº¼º½Éº´¿ø »êºÎÀΰú
Comparison of changes in serum anti-Mullerian hormone levels following laparoscopic ovarian cystectomy and myomectomy
147-GO5907:00~07:00 Áø¡ÈÖ
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
Association of plasma adiponectin and leptin in ovarian cancer development and progression
148-GO6007:00~07:00 ÃÖ¹Îö
Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú
Finding founder mutations of BRCA1 and BRCA2 in Korean ovarian cancer patients
149-GO6107:00~07:00 ÃÖÀοµ
°æ»ó´ëÇб³º´¿ø »êºÎÀΰú
Liposarcoma of the vulva
150-GO6207:00~07:00 ÃÖÁ¤ÀÎ
°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø »êºÎÀΰú
Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
151-GO6307:00~07:00 ÃÖÇöÁø
°æÈñÀÇ´ë °æÈñÀÇ·á¿ø »êºÎÀΰú
Laparoscopic splenectomy of isolated splenic metastasis for recurrence of serous ovarian cancer ; a case report
152-GO6407:00~07:00 ÇѽÃÀº
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Large cell neuroendocrine carcinoma of the endometrium with cancer-associated retinopathy in a postmenopausal woman: a case report
153-GO6507:00~07:00 ÇѽÃÀº
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Àڱ󻸷¾Ï ȯÀÚ¿¡¼­ S100A4 ´Ü¹é¹ßÇöÀÇ ÀÓ»óº´¸®ÇÐÀû Á߿伺
154-GO6607:00~07:00 ȲÇýÁø
°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø »êºÎÀΰú
A Case of Primary Malignant Mixed Mullerian Tumor of the Ovary
ÀϹݿ¬Á¦ : ºÎÀÎÁ¾¾çÇÐ - ÀϽà : 2015³â 9¿ù 18ÀÏ (±Ý)
- Àå¼Ò : ¿¡¸Þ¶öµåȦ B[3F]
GO1-GO4 (08:20~09:00) ÁÂÀå : À̳«¿ì(°í·ÁÀÇ´ë)
GO108:20~08:30 ¼Õ±Ý¼±
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Expanding Biospecimens from Korean Gynecologic Cancer Bank: Construction of Tissue Micro Arrays and Establishment of Immortalize Cell line.
GO208:30~08:40 º¯½Â¿ø
°¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú
¾ÈÁ©¸®³ª Á¹¸®ÀÇ °áÁ¤ÀÌÈÄ BRCA mutation °Ë»ç ¹× ¿¹¹æÄ¡·á¿¡ ´ëÇÑ ÀνÄÁ¶»ç
GO308:40~08:50 ÇÑ°æÈñ
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Residual ascites after neoadjuvant chemotherapy decreases treatment response and survival in patients with advanced-stage epithelial ovarian cancer
GO408:50~09:00 ±è¿µÅÂ
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
The role of re-exploration in uterine sarcoma found incidentally after initial surgery for presumed benign disease
GO5-GO8 (09:00~09:40) ÁÂÀå : ¹®Çý¼º(ÀÌÈ­ÀÇ´ë)
GO509:00~09:10 ±è¿µÅÂ
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
A scoring system to predict the risk of uterine sarcoma in patients with a uterine mass
GO609:10~09:20 ÇãÀºÁø
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
IGFBP5-derived peptide as a novel angiogenesis inhibitor for treatment of ovarian cancer
GO709:20~09:30 ¹ÚÈ¿°æ
¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú
Transvaginal ultrasound-guided biopsy of adnexal masses as a useful diagnostic alternative replacing cytology or laparoscopy in advanced ovarian cancer patients
GO809:30~09:40 ¹éÀ̼±
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma
GO9-GO12 (09:40~10:20) ÁÂÀå : ÀÌÁ¾ÇÐ(°æ»óÀÇ´ë)
GO909:40~09:50 ±è¼±¾Æ
The prevalence of HPV infection in the semen among Korean men and the effect of HPV infection on sperm parameters
GO1009:50~10:00 ÀÌ»óÈÆ
°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú
Validation of an algorithm in Korean Women Ages 21-24 years with either Atypical Squamous Cells of Undetermined Significance or Low-grade Squamous Intraepithelial Lesion
GO1110:00~10:10 À±°Ç
¾ç»êºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer
GO1210:10~10:20 À¯¼ÒÀº
The risk factors and rate for progression of cervical intraepithelial lesions in HPV 16 or 18 infected women with ASCUS or LSIL: The Korean HPV cohort study.
GO13-GO17 (10:50~11:40) ÁÂÀå : ±èÀçÈÆ(¿¬¼¼ÀÇ´ë)
GO1310:50~11:00 ±èÇöÁ¤
°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú
The impact of positive peritoneal cytology on prognosis in patients with cervical cancer: A meta-analysis
GO1411:00~11:10 ÃÖÀ±Áø
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
FROM CERVICAL INTRAEPITHELIAL NEOPLASIA TO CERVICAL SQUAMOUS CELL CARCINOMA: AN INTEGRATIVE GENOMIC ANALYSIS
GO1511:10~11:20 ±èÅÂÈÆ
¿øÀÚ·ÂÀÇÇпø »êºÎÀΰú
Outcome of salvage treatment for patients with recurrent cervical cancer; a single institutional cohort study.
GO1611:20~11:30 ¼ÛÀçÀ±
°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú
Role of p16, p63, Ki67 in a two-tier system of low-grade and high-grade squamous intraepithelial lesion
GO1711:30~11:40 ¾ç¿ì°â
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Application of oncothermia using LabEHY-100 inhibits the growth of ovarian and cervical cancer cells.
GO18-GO21 (11:40~12:30) ÁÂÀå : ¹ÚÁø¿Ï(´Ü±¹ÀÇ´ë)
GO1811:40~11:50 µ¿¸Þ¾Æ¸®
°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú
Impact of surgical staging on prognosis in patients with borderline ovarian tumors: a meta-analysis
GO1911:50~12:00 À±Á¤¿ø
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Role of diagnostic laparoscopy in advanced epithelial ovarian cancer : An experience at a single institution
GO2012:00~12:10 À±°¡¿µ
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Expression of interactive genes associated with apoptosis and their prognostic value for ovarian carcinoma
GO2112:10~12:20 Á¤À±Áö
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Identifying association between obesity and ovarian cancer based on SRA-1 gene over-expression
GO22-GO24 (13:40~14:10) ÁÂÀå : °í¼®ºÀ(´ë±¸°¡Å縯ÀÇ´ë)
GO2213:40~13:50 À̹æÇö
¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú
Efficacy of On-Q Pain Relief System for Postoperative Pain Management in Gynecologic Oncology Patients: A pilot study
GO2313:50~14:00 ±è¹Ì¼±
¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú
Identifying risk factors for CT-based diagnosed post-lymphadenectomy lower-extremity lymphedema in patients with gynecologic cancers
GO2414:00~14:10 ½Å¼¼ÀÎ
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribue to endometrial carcinogenesis
ÀϹݿ¬Á¦ : ºÎÀÎÁ¾¾çÇÐ - ÀϽà : 2015³â 9¿ù 18ÀÏ (±Ý)
- Àå¼Ò : ´ÙÀ̾ƸóµåȦ[3F]
GO25-GO28 (15:10~15:50) ÁÂÀå : À̼±°æ(°æÈñÀÇ´ë)
GO2515:10~15:20 ¹ÚÁöÀº
Ä¥°î°æºÏ´ëÇб³º´¿ø »êºÎÀΰú
Prognostic value of F-18 PET metabolic parameters of regional lymph node in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy
GO2615:20~15:30 ³²¼¼Çö
¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø »êºÎÀΰú
Efficacy of TachoSil¢ç in preventing hemorrhage after loop electrosurgical excision procedure
GO2715:30~15:40 Á¤À¯¿¬
°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø »êºÎÀΰú
Clipping during distal external iliac lymphadenectomy increases lower leg lymphedema in patients with carcinoma of the cervix
GO2815:40~15:50 µµ¾Æ¿µ
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Prognostic factors affected survival outcome of recurrent cervical cancer patients with pulmonary metastases without other organs involvement
GO29-GO31 (15:50~16:20) ÁÂÀå : Á¤ÀºÈ¯(ÃæºÏÀÇ´ë)
GO2915:50~16:00 À̵ÎÇà
¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø »êºÎÀΰú
Effect of menstrual phase on the surgical treatment of ovarian cyst
GO3016:00~16:10 À̼¼¿¬
Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú
Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumor at reproductive age
GO3116:10~16:20 Á¤ÀºÁÖ
¿ï»ê´ëÇб³º´¿ø »êºÎÀΰú
Frequency of a non-rising increase of serum CA-125 levels during chemotherapy treatment in recurrent patients of advanced epithelial ovarian cancer (EOC) after reviously being treated optimally